Global /South Korea /Healthcare /Medical Devices /290650

L&C BIO Co.,LTD

290650

• KRX: 290650 • Delayed

63,200KRW -9.6%

41.23 USD

As of 5 June 2026, L&C BIO Co.,LTD has a market cap of $1.13B USD, ranking #10040 globally and #272 in South Korea. It ranks #885 in the Healthcare sector, and #180 in the Medical Devices industry.

Global Rank

10040

Country Rank

272

Sector Rank

885

Industry Rank

180

Key Stats

Market Cap

$1.13BUSD

1.74T KRW

Enterprise Value

$1.18BUSD

1.8T KRW

Revenue (TTM)

$55.76MUSD

85.48B KRW

EBITDA (TTM)

$7.6MUSD

11.65B KRW

Net Income (TTM)

-$90.14MUSD

-138.17B KRW

EBITDA Margin

14%

Profit Margin

-162%

PS Ratio

20.3

PB Ratio

8.3

EV/EBITDA

158.1

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Medical Devices

CEO

Chul Lee Whan open_in_new

Employees

141

Founded

2011

Website

lncbio.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-9.6%	-9.6%	-14%	-19%	21%	3.6%	193%	106%	93%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	290650 (주)엘앤씨바이오 Ordinary Shares ISIN: KR7290650001 Shares Out.: Shares Outstanding: 26.737M¹ Shares Float: 18.674M² TV: TradingView: KRX: 290650 SA: Stock Analysis: KRX: 290650 YF: Yahoo Finance: 290650.KS GF: Google Finance: KRX: 290650 BA: Barron's: 290650 MS: Morningstar: XKRX: 290650	63,200 KRW	TV: TradingView: KRX: 290650 SA: Stock Analysis: KRX: 290650 YF: Yahoo Finance: 290650.KS GF: Google Finance: KRX: 290650 BA: Barron's: 290650 MS: Morningstar: XKRX: 290650

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About L&C BIO Co.,LTD

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C Bio Co., Ltd was founded in 2011 and is headquartered in Seongnam-si, South Korea.

Similar Companies

Industry: Medical Devices (South Korea)

Name	Market Cap (USD) diff.	PE	Country
CLASSYS Inc. KRX: 214150	$2.45B 3.75T KRW 116%	28.7	South Korea
SEERS Co., Ltd. KRX: 458870	$1.22B 1.86T KRW 7.4%	114.8	South Korea
Livsmed Inc. KRX: 491000	$1.18B 1.81T KRW 4.2%	-	South Korea
Seegene, Inc. KRX: 096530	$753.63M 1.16T KRW -33%	23.9	South Korea
i3system Inc. KRX: 214430	$528.2M 809.64B KRW -53%	83.3	South Korea
ToolGen Inc. KRX: 199800	$522.65M 801.13B KRW -54%	-	South Korea

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 15K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 14K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 14K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 11K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 11K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 9K%	22.2	Ireland

chevron_leftBack